![](/img/cover-not-exists.png)
Two year follow-up of Crohn’s patients substituted to certolizumab anti-TNFa therapy: SAVANT 2
Motlis, Andrew, Boktor, Moheb, Jordan, Paul, Cvek, Urska, Trutschl, Marjan, Alexander, J. StevenLanguage:
english
Journal:
Pathophysiology
DOI:
10.1016/j.pathophys.2017.07.004
Date:
August, 2017
File:
PDF, 567 KB
english, 2017